NM
NAHUM MENDEZ-SANCHEZ
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Hospital Médica Sur
Research areas: Medicine · Hepatology · Liver Disease Diagnosis and Treatment · Liver Disease and Transplantation · Liver Diseases and Immunity
0000-0001-5257-8048
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (62)
- The Simplest Hepatoprotective Intervention? Coffee in the Era of Precision Hepatology Save
- Carga creciente de la cirrosis por colangitis biliar primaria en México: evidencia de una cohorte multicéntrica contemporánea Save
- Pirfenidone as a Pleiotropic Antifibrotic Agent in Metabolic Steatohepatitis: From Mechanisms to Clinical Evidence Save
- From NAFLD to MASLD and MetALD: Conceptual Shifts in Metabolic Liver Disease and Their Implications for Mexico Save
- The interplay of insulin resistance, glycemic variability, and metabolic dysfunction-associated steatotic liver disease Save
- Epidemiology and etiologic trends of hepatocellular carcinoma in cirrhotic patients in Mexico: a multicenter retrospective study (2018–2024) Save
- Efficacy and safety of statins for nonalcoholic/metabolic dysfunction-associated fatty liver diseases: a systematic review and meta-analysis Save
- GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications Save
- Hot Topics in Gastroenterology and Hepatology Save
- Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets Save
- Probiotics for the Management of Liver Cirrhosis and Its Complications Save
- Organokine-Mediated Crosstalk: A Systems Biology Perspective on the Pathogenesis of MASLD—A Narrative Review Save
- Changing Landscape of Liver Cirrhosis Etiologies Save
- How the gut-liver axis shapes hepatic encephalopathy: mechanistic and therapeutic perspectives Save
- Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990–2021 Save
- The Mechanisms behind Thrombocytopenia in Patients with Portal Hypertension and Chronic Liver Disease Save
- Metabolic Divergence Between MASLD and Metabolic Syndrome: Distinct Clinical Phenotypes and Risk Stratification Implications Save
- Preface Save
- Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia Save
- Global Burden of Major Chronic Liver Diseases in 2021 Save